CYBIN
Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, United Kingdom and Ireland. The Company is focused on progressing Psychedelics to Therapeutics™ by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health disorders.
CYBIN
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2019-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.cybin.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
124.28 M CAD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-12-14 | Adelia Therapeutics | Adelia Therapeutics acquired by Cybin | 20.16 M CAD |
Investors List
Bail Capital
Bail Capital investment in Series B - Cybin
Life Sciences Partners
Life Sciences Partners investment in Series B - Cybin
RA Capital Management
RA Capital Management investment in Series B - Cybin
Subversive Capital
Subversive Capital investment in Series B - Cybin
Noetic Fund
Noetic Fund investment in Series B - Cybin
Kearny Venture Partners
Kearny Venture Partners investment in Series B - Cybin
Janus Henderson Investors
Janus Henderson Investors investment in Series B - Cybin
Innovating Capital
Innovating Capital investment in Seed Round - Cybin
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-01 | Cybin Announces Appointment of Dr. Amir Inamdar as Chief Medical Officer for European Operations and Dr. Geoff Varty as the Head of Research and Development |
Official Site Inspections
http://www.cybin.com Semrush global rank: 1.98 M Semrush visits lastest month: 10.8 K
- Host name: 77.141.27.34.bc.googleusercontent.com
- IP address: 34.27.141.77
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
